1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Impact of COVID-19
on Global Over the Counter (OTC) Drugs Market
5. Voice of Customer
6.
Global Over the Counter (OTC) Drugs Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements
(VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others)
6.2.2. By Dosage Form (Tablets, Capsules, Liquids & Solutions,
Cream/Lotion/Ointments, Others)
6.2.3. By Route of Administration (Oral, Parenteral, Topical, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2022)
6.3. Market Map
7.
Asia Pacific Over the Counter (OTC) Drugs Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Product
7.2.2. By Dosage Form
7.2.3. By Route of Administration
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Asia Pacific:
Country Analysis
7.3.1. China Over the
Counter (OTC) Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Dosage Form
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By Distribution Channel
7.3.2. India Over the
Counter (OTC) Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Dosage Form
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By Distribution Channel
7.3.3. Australia Over the
Counter (OTC) Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Dosage Form
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By Distribution Channel
7.3.4. Japan Over the
Counter (OTC) Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Dosage Form
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By Distribution Channel
7.3.5. South Korea Over the
Counter (OTC) Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Dosage Form
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By Distribution Channel
8.
Europe Over the Counter (OTC) Drugs Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Dosage Form
8.2.3. By Route of Administration
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Europe: Country
Analysis
8.3.1. France Over the
Counter (OTC) Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Dosage Form
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By Distribution Channel
8.3.2. Germany Over the
Counter (OTC) Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Dosage Form
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By Distribution Channel
8.3.3. Spain Over the
Counter (OTC) Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Dosage Form
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By Distribution Channel
8.3.4. Italy Over the
Counter (OTC) Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Dosage Form
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By Distribution Channel
8.3.5. United Kingdom Over
the Counter (OTC) Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Dosage Form
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By Distribution Channel
9.
North America Over the Counter (OTC) Drugs Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Product
9.2.2. By Dosage Form
9.2.3. By Route of Administration
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. North America:
Country Analysis
9.3.1. United States Over
the Counter (OTC) Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Dosage Form
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By Distribution Channel
9.3.2. Mexico Over the
Counter (OTC) Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Dosage Form
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By Distribution Channel
9.3.3. Canada Over the
Counter (OTC) Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Dosage Form
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By Distribution Channel
10.
South America Over the Counter (OTC) Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product
10.2.2. By Dosage Form
10.2.3. By Route of Administration
10.2.4. By Distribution Channel
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Over the
Counter (OTC) Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Dosage Form
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By Distribution Channel
10.3.2. Argentina Over the
Counter (OTC) Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Dosage Form
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By Distribution Channel
10.3.3. Colombia Over the
Counter (OTC) Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Dosage Form
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By Distribution Channel
11.
Middle East and Africa Over the Counter (OTC) Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Product
11.2.2. By Dosage Form
11.2.3. By Route of Administration
11.2.4. By Distribution Channel
11.2.5. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa Over
the Counter (OTC) Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Dosage Form
11.3.1.2.3.
By Route of Administration
11.3.1.2.4.
By Distribution Channel
11.3.2. Saudi Arabia Over
the Counter (OTC) Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Dosage Form
11.3.2.2.3.
By Route of Administration
11.3.2.2.4.
By Distribution Channel
11.3.3. UAE Over the Counter
(OTC) Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Dosage Form
11.3.3.2.3.
By Route of Administration
11.3.3.2.4.
By Distribution Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
13.1.
Recent Developments
13.2.
Product Launches
13.3.
Mergers & Acquisitions
14. Global Over the
Counter (OTC) Drugs Market: SWOT Analysis
15.
Porter’s Five Forces Analysis
15.1.
Competition in the Industry
15.2.
Potential of New Entrants
15.3.
Power of Suppliers
15.4.
Power of Customers
15.5.
Threat of Substitute Product
16. PESTLE Analysis
17. Competitive
Landscape
17.1.
Sanofi SA
17.1.1. Business Overview
17.1.2. Company Snapshot
17.1.3. Products &
Services
17.1.4. Financials (In case
of listed companies)
17.1.5. Recent Developments
17.2.
Pfizer Inc.
17.3.
GlaxoSmithKline plc
17.4.
Perrigo Company plc
17.5.
Reckitt Benckiser Group PLC
17.6.
Takeda Pharmaceutical Company Ltd
17.7.
Boehringer Ingelheim International GmbH
17.8.
Sun Pharmaceutical Industries Ltd.
17.9.
Teva Pharmaceutical Industries Ltd.
17.10.
Glenmark Pharmaceuticals Ltd.
18.
Strategic
Recommendations
19. About Us & Disclaimer